PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Sodium Tetradecyl Sulfate→

Sodium Tetradecyl Sulfate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
139-88-8
Molecular formula
C14H29NaO4S
Molecular weight
316.43 g/mol
Drug class
Anionic surfactant sclerosantdetergent-type venous sclerotherapy agent
Mechanism of action
Disrupts endothelial-cell membranes in the treated vein, causing endothelial injury, thrombosis and subsequent fibrotic occlusion of the vessel. Sodium is a counter-ion and does not create a different sclerosant target.
Indications / reported uses
  • Sclerotherapy of suitable varicose veins and venous malformations in appropriately selected patients; strength, foam/solution technique and target vessel are product- and jurisdiction-specific

Sources: US DailyMed — Sodium tetradecyl sulfate injection · NICE — Varicose veins: diagnosis and management

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Sodium Tetradecyl Sulfate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Sodium Tetradecyl Sulfate Permitted Daily Exposure (PDE) report (the Sodium Tetradecyl Sulfate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Sodium Tetradecyl Sulfate Occupational Exposure Limit (OEL) report (the Sodium Tetradecyl Sulfate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.